Sandra S. Axtell, PharmD, BCPS

Sandra S. Axtell, PharmD, BCPS

Clinical Pharmacy Specialist
Ambulatory Care-Internal Medicine/Drug Information
Hillcrest Hospital
Phone: 440.312.4396
Email: saxtell@ccf.org

Clinical specialist at Hillcrest since 2001

Education

  • Doctor of Pharmacy, Duquesne University, Pittsburgh, PA
  • Bachelor of Science in Pharmacy, State University of New York at Buffalo, Buffalo, NY
  • Pharmacy Practice Residency, Buffalo General Hospital, Buffalo, NY
  • Board Certified Pharmacotherapy Specialist
  • Diabetes Care Certificate Training for Pharmacists
  • Delivering MTM Services Certificate Training for Pharmacists

Areas of Interest

  • Ambulatory Care-Internal Medicine/Family Medicine
  • Drug Information

Current Projects

  • Ambulatory Care Services with Internal Medicine /Family Medicine
  • Compile adverse drug reaction reports for quarterly review

Service

  • Chair Preceptor/Resident Development Committee 
  • Chair Pharmacy Sub-Group Committee
  • ACCP Pharmacotherapy Self-Assessment Program (PSAP) 2017 Book 1 (Endocrinology/Nephrology) pilot tester
  • Pharmacy and Therapeutics Committee member
  • Ambulatory Care Practice committee member
  • Member of ACCP
  • Member of ASHP
  • Member of CSHP

Teaching

  • Serve as preceptor for pharmacy residents and PharmD students
  • Serve as preceptor for nurse practitioner students
  • Provide continuing education to nurses, pharmacists and physicians at Hillcrest Hospital

Honors and Awards

  • Quality Management Silver award 2004 – Improving sedation and analgesia in critical care patients
  • Quality Management Bronze award 2003 - Decreasing post-operative infection rates

Publications

  • Delisle M, Axtell S. What are the long-term risks for continuing PPI treatment? OSHP Bulletin 2017; 37(1):5,8.
  • Walker K, Axtell S.  What is the evidence to support the initiation of a GLP-1 receptor agonist over basal insulin when oral therapies have failed? OSHP Bulletin 2016; 36(6):4
  • Herschman M, Rigelsky F, Axtell S. A pilot study comparing hospital readmission rates in patients receiving rivaroxaban or enoxaparin after orthopedic surgery. P T 2016; 41(6):376-80.
  • Fink K, Axtell S. What drug combinations or patient characteristics increase risk of serotonin syndrome? OSHP Bulletin 2016; 36(1):4.
  • Herschman M, Axtell S. What patient population should receive aspirin for VTE prophylaxis after orthopedic surgery? OSHP Bulletin 2015; 35(5):4.
  • Funelli K, Axtell S. What is the most appropriate dosing of enoxaparin for pulmonary embolism? OCCP Newsletter. OCCP Newsletter 2015; 2:2-3.
  • Herschman M, Axtell S. Does metformin require discontinuation prior to administration of all types of contrast media? OCCP Newsletter 2015; 2:5.
  • Pasternak A, Axtell S. What is the Risk of Developing Diabetes Mellitus (DM) while taking a Statin? OSHP Bulletin 2014; 34(6):4-5.
  • Sodhi M, Axtell SS, Callahan J, Shekar RJ. Is it safe to use carbapenems in patients with a history of allergy to penicillin? Antimicrob Chemother. 2004 Dec; 54(6):1155-7.
  • Axtell SS, Ludwig E, Lopez-Candales A. Intervention to improve adherence to ACC/AHA recommended adjunctive medications for the management of patients with an acute myocardial infarction. Clinical Cardiology 2001; 24:114-8.
  • Fetrow CW, Avila JR. Contributing Authors Axtell S, et al. Professional’s Handbook of Complementary & Alternative Medicines 2nd Edition. Springhouse, PA: Springhouse 2001.
  • Fetrow CW, Avila JR. Contributing Authors Axtell S, et al. Professional’s Handbook of Complementary & Alternative Medicines. Springhouse, PA: Springhouse 1999.
  • Fetrow CW, Avila JR. Contributing Authors Axtell S, et al. The Complete Guide to Herbal Medicines. Springhouse, PA: Springhouse 1999.

Poster Presentations

  • Axtell S, et al. Co-investigator.  ASHP Midyear Clinical Meeting December 2016.  Apixaban Usage in Atrial Fibrillation Patients in a 500-bed Tertiary Care Medical Facility.
  • Axtell S, et al. Co-investigator. OCCP Spring Meeting May 2015. A pilot study comparing hospital readmission rates in patients that received rivaroxaban versus enoxaparin following orthopedic surgery.
  • Axtell S, et al. Co-investigator. ASHP Midyear Clinical Meeting December 2014. Evaluation of the Safety and Efficacy of Sitagliptin Therapy in Hospitalized Patients in a Community-teaching Hospital.
  • Axtell S, et al. Co-investigator. OCCP Spring Meeting May 2014. Insulin Sliding Scale and Hypoglycemia in Non-Critical Patients.
  • Axtell S, et al. Co-investigator. ASHP Annual Clinical Meeting June 2013. Evaluation of Medication-Related Hypoglycemic Events in Non-Intensive Care Unit Patients.
  • Axtell S, et al. Co-investigator. ASHP Midyear Clinical Meeting December 2005. Medication Management Pharmacist: Meeting the Quality Measures - One Year Later.
  • Axtell S, et al. Co-investigator. ASHP Midyear Clinical Meeting December 2004. Medication Management Pharmacist: Meeting the Core Measures.
  • Axtell S, et al. Co-investigator. ACCP Annual Meeting October 2004. A Retrospective Drug Use Evaluation of Epoetin Alfa and Darbepoetin Alfa within the Cleveland Clinic Health System.
  • Axtell S, et al. Co-investigator. ASHP Midyear Clinical Meeting December 2003. Sedation and Analgesia for Mechanically Ventilated Critical Care Patients.
  • Axtell S, et al. Primary investigator. ASHP Midyear Clinical Meeting December 2002. Implementation of a Pharmacist Initiated IV to PO Automatic Conversion Program.
  • Axtell S, et al. Primary investigator. ASHP Midyear Clinical Meeting December 2001. Implementation of a Renal Dose Monitoring Program to Reduce Potential Adverse Drug Events.
  • Axtell S, et al. Primary investigator. ASHP Midyear Clinical Meeting December 2001. Management of Community Acquired Pneumonia: A Comparison between Two Hospitals.
  • Axtell S. Primary investigator. Eastern States Conference for Pharmacy Residents and Preceptors April 1999, Baltimore, MD. Improving Adherence to ACC/AHA Adjunctive Medicinal Therapy Guidelines for Patients with an Acute Myocardial Infarction
  • Axtell S, et al. Primary investigator. ASHP Midyear Clinical Meeting December 2000. A Drug Utilization Review of the Proton Pump Inhibitor Pantoprazole (Protonix).
  • Axtell S, et al. Co-investigator. ASHP Midyear Clinical Meeting December 1997. Defining a New Therapeutic Range for Heparin.

Lecture Presentations

  • Parkinson Disease- Pharmacy CE Program February 2013, Hillcrest Hospital.
  • Drug Information Resources- Pharmacy CE Program May 2012, Hillcrest Hospital.
  • Type 1 Diabetes- Pharmacy CE Program May 2012, Hillcrest Hospital.
  • Antibiotic Selection Guidelines, Pharmacist is In Program - 2003 and 2004 graduate nursing student lectures, South Pointe Hospital -Warrensville Heights, OH
  • Aminoglycoside and Vancomycin Dosing Guidelines- Pharmacy CE Program September 2003, Hillcrest Hospital.
  • Antibiotic Selection Guidelines, CSHP CE Program August 2003, Chesterland, OH